We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,579 results
  1. Erythroleukemia: an Update

    Purpose of the Review

    Acute erythroleukemia (AEL) is a rare form of acute myeloid leukemia recognized by erythroblastic proliferation. Many...

    Olga K. Weinberg, Daniel A. Arber in Current Oncology Reports
    Article 20 April 2021
  2. GPS2 promotes erythroid differentiation in K562 erythroleukemia cells primarily via NCOR1

    G protein pathway suppressor 2 (GPS2) has been shown to play a pivotal role in human and mouse definitive erythropoiesis in an EKLF-dependent manner....

    Ying Lu, Wen-Bing Ma, ... Rong-Hua Yin in International Journal of Hematology
    Article 30 May 2024
  3. LSD1-mediated repression of GFI1 super-enhancer plays an essential role in erythroleukemia

    Super-enhancers (SEs) consist of enhancer clusters with abundant binding of transcription factors (TFs) and cofactors. LSD1 is a histone modifier...

    Goichi Tatsumi, Masahiro Kawahara, ... Akira Andoh in Leukemia
    Article 01 November 2019
  4. Apoptosis induction and cell cycle arrest of pladienolide B in erythroleukemia cell lines

    Splicing of pre-mRNA into functional mRNA, carried out by the spliceosome, represents a crucial step in eukaryotic gene expression. Mutations and...

    Joana Jorge, Sara Petronilho, ... Ana Bela Sarmento-Ribeiro in Investigational New Drugs
    Article 31 May 2019
  5. Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML

    Leukemogenic SHP2 mutations occur in 35% of patients with juvenile myelomonocytic leukemia (JMML), a rare but fatal hematopoietic malignancy without...

    Yuming Zhao, Chunxiao He, ... Yun Chen in Experimental Hematology & Oncology
    Article Open access 20 February 2023
  6. FLI1 accelerates leukemogenesis through transcriptional regulation of pyruvate kinase-L/R and other glycolytic genes

    In cancer cells, multiple oncogenes and tumor suppressors control glycolysis to sustain rapid proliferation. The ETS-related transcription factor...

    Danmei Sheng, Beiling Chen, ... Yaacov Ben-David in Medical Oncology
    Article 31 December 2022
  7. The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice

    Transcription factor GATA1 controls the delicate balance between proliferation, differentiation and apoptosis in both the erythroid and...

    Daishi Ishihara, Atsushi Hasegawa, ... Ritsuko Shimizu in Experimental Hematology & Oncology
    Article Open access 26 February 2024
  8. UM171 suppresses breast cancer progression by inducing KLF2

    Purpose

    Breast cancer is the most frequent cancer in women with significant death rate. Morbidity is associated with drug resistance and metastasis....

    **aojuan Ran, Anling Hu, ... Yaacov Ben-David in Breast Cancer Research and Treatment
    Article Open access 14 June 2024
  9. Strain-dependent modifiers exacerbate familial leukemia caused by GATA1-deficiency

    GATA1 plays a critical role in differentiation, proliferation, and apoptosis during erythropoiesis. We developed a Gata1 knock-down allele ( Gata1.05 )...

    Ikuo Hirano, Kanako Abe, ... Ritsuko Shimizu in Experimental Hematology & Oncology
    Article Open access 26 February 2024
  10. MARCH3 negatively regulates IL-3-triggered inflammatory response by mediating K48-linked polyubiquitination and degradation of IL-3Rα

    Interleukin-3 (IL-3) is a hematopoietic growth factor and critical regulator of inflammatory response such as sepsis. IL-3 binds to IL-3 receptor α...

    Lu Feng, Chen Li, ... Shu Li in Signal Transduction and Targeted Therapy
    Article Open access 24 January 2022
  11. Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancers

    Chimeric antigen receptor (CAR)-engineered immune effector cells constitute a promising approach for adoptive cancer immunotherapy. Nevertheless,...

    Jordi Pfeifer Serrahima, Congcong Zhang, ... Winfried S. Wels in Cancer Immunology, Immunotherapy
    Article Open access 23 January 2023
  12. The roles of FHL2 in cancer

    LIM domain protein 2, also known as LIM protein FHL2, is a member of the LIM-only family. Due to its LIM domain protein characteristics, FHL2 is...

    Jiawei Zhang, Qun Zeng, Meihua She in Clinical and Experimental Medicine
    Article 27 April 2023
  13. OT-82, a novel anticancer drug candidate that targets the strong dependence of hematological malignancies on NAD biosynthesis

    Effective treatment of some types of cancer can be achieved by modulating cell lineage-specific rather than tumor-specific targets. We conducted a...

    Lioubov Korotchkina, Denis Kazyulkin, ... Andrei V. Gudkov in Leukemia
    Article Open access 02 January 2020
  14. Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors

    Nowadays, natural killer (NK) cell-based immunotherapy provides a practical therapeutic strategy for patients with advanced solid tumors (STs). This...

    Hamid Khodayari, Saeed Khodayari, ... Karim Nayernia in Cancer Immunology, Immunotherapy
    Article 04 July 2021
  15. A research review of experimental animal models with myelodysplastic syndrome

    Myelodysplastic syndrome (MDS) consists of a group of hematologic tumors that are derived from the clonal proliferation of hematopoietic stem cells,...

    Gen-Wang Chen, Mei-Na Chen, ... Yue-Zu Chen in Clinical and Translational Oncology
    Article 06 September 2022
  16. Anticancer activity of lycopene in HT-29 colon cancer cell line

    An inverse association between serum lycopene levels and the risk of cancers has been pointed out by many prospective and retrospective...

    Dilara Ataseven, Ayşegül Öztürk, ... Ziad Joha in Medical Oncology
    Article 24 March 2023
  17. SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

    KMT2A -rearranged (KMT2A-R) is an aggressive and chemo-refractory acute leukemia which mostly affects children. Transcriptomics-based characterization...

    Antonella Di Mambro, Yoana Arroyo-Berdugo, ... Maria Teresa Esposito in Oncogene
    Article Open access 27 October 2023
  18. BCR-ABL induces tyrosine phosphorylation of YAP leading to expression of Survivin and Cyclin D1 in chronic myeloid leukemia cells

    In the present study, we studied downstream signals of BCR-ABL with regard to Src family kinases and YAP, a transcription cofactor and an effector of...

    Kenta Moriyama, Toshiyuki Hori in International Journal of Hematology
    Article 19 August 2019
  19. Three distinct hematological malignancies from a single germ cell tumor: a case report

    Background

    The association between non seminomatous germ cell tumors (GCTs) and hematological malignancies of rare lineage has been described in the...

    M. Spencer Chapman, P. C. May, ... E. Nadal Melsio in Journal of Medical Case Reports
    Article Open access 17 November 2020
  20. Hematopoietic stem cells suppress proliferation and enhance differentiation of leukemia cells through regulating apoptotic and inflammatory genes

    Purpose

    Stem cells are known to play an important role in tumor treatment and many of them have shown tumor-suppressing ability in different cancers;...

    Bo Li, Can Can, ... Daoxin Ma in Journal of Cancer Research and Clinical Oncology
    Article 11 October 2023
Did you find what you were looking for? Share feedback.